Achievement of ESC/EAS lipid treatment goals with evolocumab in patients with type 2 diabetes: analyses of the Banting and Berson trials - Media Centre | EASD
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
Comparison of Transatlantic Approaches to Lipid Management: The AHA/ACC/Multisociety Guidelines vs the ESC/EAS Guidelines - Mayo Clinic Proceedings
Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI | SpringerLink
UAS Home Page
![PDF] 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2677d05e0615fb7c44c784b83ad90687fe00d60d/12-Figure1-1.png "PDF] 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. | Semantic Scholar")
PDF] 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. | Semantic Scholar
Fernando de la Guía on Twitter: "🚩#ESCCongress Guías Dislipemia 2019 ESC/ EAS Guidelines for the management of #dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of
ESC/EAS 2019 International Guidelines
The 2019 ESC/EAS Dyslipidemia Guidelines from the point of view of the European Atherosclerosis Society - PACE-CME
Lipid-lowering therapy use in primary and secondary care in Central and Eastern Europe: DA VINCI observational study - ScienceDirect
ESC/EAS Guidelines for the management of dyslipidemias
ESC Guidelines quiz | The return of the ESC Guidelines quiz in full force 💪 According to the 2019 ESC/EAS Guidelines for the management of dyslipidaemias, which of the... | By European
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis
EAS/ESC Guidelines Summary - Benecol HCP - UK
Table 5 from 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. | Semantic Scholar
ESC/EAS Guidelines dyslipidaemias 2019 - PACE-CME
